Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
THE OPPORTUNITY Are you an AI-native software engineer ready to help enterprises stay visible in the era of AI? The Adobe Brand Visibility team builds the systems that determine how enterprise brands appear in ChatGPT, Gemini,
THE OPPORTUNITY The way brands are discovered online is changing as search engines, AI assistants, and large language models increasingly shape how users find information and interact with content. Adobe’s Domain Experts team operates where SEO,